deCODE biostructures Expands Collaboration with InterMune

Scientists from the University of Bristol have designed a new synthetic glucose binding molecule platform that brings us one step closer to the development of the world's first glucose-responsive insulin which, say researchers, will transform the treatment of diabetes.

UNIGE researchers have identified a molecule that can halt the progress of a severe genetic disease that causes whole-body muscle paralysis followed by death.

The pair of Colorado State University organic chemists have forged a powerful new tool for drug hunters - a simple, elegantly designed chemical reaction that could fling open an underexplored wing of biologically relevant chemistry.